Professor Ann Henry and Dr Fin Slevin are leading the POINTER-PC trial, featured by Yorkshire Cancer Research. This large trial is investigating whether a shorter course of radiotherapy can better treat prostate cancer that has returned following the initial course of treatment. It will also explore whether widening the area targeted by radiotherapy will be more effective at stopping the cancer from spreading. The first participant in the POINTER-PC trial is a Bradford patient who found that there were far fewer hospital visits during the trial compared to his first round of treatment in 2017, and this was a kinder treatment too: “I’d go in, have the treatment, and carry on with my day. Not long after I finished my final session, I felt well enough to fly to Madeira for our annual winter holiday.”
